Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

RiboGene and Pharmacopeia to discover antiinfective compounds

Oct. 30, 1997

Anti-HCMV pseudopeptides disclosed by Bayer

Oct. 30, 1997

Diester prodrugs of antiviral acyclic nucleoside disclosed by Medivir

Oct. 29, 1997

Lamisil's safety profile confirmed

Oct. 28, 1997

Sankyo isolates antibacterial agent F-12436

Oct. 23, 1997

PathoGenesis initiates phase II trial with new antiinfective for tuberculosis

Oct. 22, 1997

New nonimmunosuppressive CsA derivative with potent anti-Toxoplasma activity

Oct. 22, 1997

Taisho, Abbott to collaborate on macrolide antibacterials

Oct. 21, 1997

NIH researcher outlines ups and downs of malaria vaccine research

Oct. 21, 1997

Anti-Infective Drugs Advisory Committee to discuss three NDAs

Oct. 20, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...